Please assess the completion status of the following clinical trial:

Trial Title: Combination of Taliderm® and Vacuum-assisted Closure (VAC) for Treatment of Pressure Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: EARLY_PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Ischial/sacral Pressure ulcer between 4 and 15cm diameter~* Greater than or equal to 18 years of age~* Ability to obtain informed consent~Exclusion Criteria:~* Connective tissue disorders~* Immunosuppression, Hemodialysis, Steroids~* Pregnancy~* Sepsis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- wound dressing with VAC (Type: SHAM_COMPARATOR): After wound debridement wounds are treated for 2 weeks with VAC dressing alone
- wound dressing with VAC and sNAG under Antiaggregation (Type: OTHER): In patients being under antiaggregation with Aspirin® 100mg daily, after wound debridement wounds are treated with VAC and sNAG
- wound dressing with VAC and sNAG without antiaggregation (Type: EXPERIMENTAL): In patients NOT being under antiaggregation, after wound debridement wounds are treated with VAC and sNAG

Based on this trial design, predict the completion outcome and termination type (if applicable).